Nakata N, Sakurada S, Sakurada T, Tan-No K, Kisara K
Department of Pharmacology, Tohoku College of Pharmacy, Sendai, Japan.
Methods Find Exp Clin Pharmacol. 1998 Apr;20(3):193-8.
[D-Arg2,Sar4]-dermorphin (1-4) [DAS-DER (1-4)] was compared with morphine for the capacity to affect mouse gastrointestinal transit and electrically evoked contractions of the guinea pig ileum (GPI). A single subcutaneous injection with DAS-DER (1-4) and morphine dose-dependently inhibited gastrointestinal transit of charcoal in mice. DAS-DER (1-4) with ID50 of 0.053 mg/kg was 26 times more potent than morphine with ID50 of 1.38 mg/kg. The inhibitory effects of DAS-DER (1-4) and morphine were completely inhibited by pretreatment with 1 mg/kg naloxone, an opioid receptor antagonist. The GPI contraction was inhibited by DAS-DER (1-4) with an IC50 of 6.9 +/- 0.7 nM and morphine with an IC50 of 295.0 +/- 11.8 nM, respectively. These effects were also inhibited by preincubation with naloxone. Repeated subcutaneous injections of DAS-DER (1-4) and morphine to guinea pigs produced tolerance to the inhibitory effect on electrically evoked contractions of GPI. Moreover, a marked cross tolerance was seen in guinea pigs made tolerant to DAS-DER (1-4) or morphine. The present study indicates that pharmacological profiles of DAS-DER (1-4) as assayed by the gastrointestinal transit and stimulated contractions of the GPI were almost similar to that of morphine.
将[D-精氨酸2,肌氨酸4]-皮啡肽(1-4)[DAS-DER(1-4)]与吗啡对小鼠胃肠道转运及豚鼠回肠(GPI)电诱发收缩的影响能力进行了比较。单次皮下注射DAS-DER(1-4)和吗啡可剂量依赖性地抑制小鼠木炭的胃肠道转运。DAS-DER(1-4)的半数抑制剂量(ID50)为0.053mg/kg,其效力比ID50为1.38mg/kg的吗啡强26倍。用1mg/kg阿片受体拮抗剂纳洛酮预处理可完全抑制DAS-DER(1-4)和吗啡的抑制作用。DAS-DER(1-4)和吗啡对GPI收缩的抑制作用的半数抑制浓度(IC50)分别为6.9±0.7nM和295.0±11.8nM。这些作用也可被与纳洛酮预孵育所抑制。对豚鼠重复皮下注射DAS-DER(1-4)和吗啡会使其对GPI电诱发收缩的抑制作用产生耐受性。此外,对DAS-DER(1-4)或吗啡产生耐受性的豚鼠出现了明显的交叉耐受性。本研究表明,通过胃肠道转运和GPI刺激收缩测定的DAS-DER(1-4)的药理学特征与吗啡几乎相似。